Strongyloidiasis
📧 Sign up to get email alerts when something new happens for Strongyloidiasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-04-07FDA Approved: IVERMECTIN — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s original ANDA for ivermectin, making a generic version of the product available for human use. The app…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
A National Institute of Allergy and Infectious Diseases sponsored clinical trial evaluating how to evaluate, treat, and monitor patients wit…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Strongyloidiasis at CHRU Nancy: Evaluation of the Performance of Serological Tests and Disease-associated Characteristics
A completed clinical trial conducted at CHRU Nancy evaluated the performance of serological tests for Strongyloidiasis and described disease…
-
CLINICAL_TRIALS other · 2025-09-08Clinical Trial Update: Better Options for Lymphatic Filariasis Treatment [Phase 3]
A Phase 3 clinical trial aiming to improve treatment options for lymphatic filariasis is described, with related conditions including scabie…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Strongyloides Stercoralis Public Health Control in Rwanda
A clinical trial evaluating public health control measures for Strongyloides stercoralis infection in Rwanda has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Delivering a Multi-disease Screening Tool to Migrant Populations [NA]
This update reports the completion of a trial evaluating a multi-disease screening tool for migrant populations. The study targeted HIV, hep…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Efficacy and Safety of Emodepside in Adults Infected With Strongyloidiasis Stercoralis [Phase 2]
This document reports the results of a Phase 2 trial assessing the efficacy and safety of emodepside in adults infected with Strongyloides s…
-
FDA approval · 2024-09-04FDA Approved: ALBENDAZOLE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals' original application for albendazole, adding a generic version to the market.
-
FDA approval · 2024-08-19FDA Approved: IVERMECTIN — Supplemental Application (Edenbridge Pharmaceuticals LLC.)
FDA approved a supplemental application for IVERMECTIN from Edenbridge Pharmaceuticals LLC (ANDA 204154). This action updates the approval s…
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: Treatment of Strongyloides Infection [Phase 3]
Phase 3 trial update for treatment of Strongyloides infection; trial terminated with results posted.
-
FDA approval · 2022-08-02FDA Approved: IVERMECTIN — Original Application (Viona Pharmaceuticals Inc)
FDA approves an original ANDA for ivermectin tablets from Viona Pharmaceuticals Inc, enabling a generic version of the antiparasitic for cer…
-
CLINICAL_TRIALS trial_result · 2022-02-24Clinical Trial Update: Adjunctive Ivermectin Mass Drug Administration for Malaria Control [Phase 3]
Phase 3 clinical trial update on adjunctive ivermectin MDA for malaria control and related neglected tropical diseases.
-
FDA approval · 2020-07-09FDA Approved: IVERMECTIN — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Actavis Pharma’s ivermectin, confirming approval of its generic antiparasitic product.
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs ) [Phase 3]
A Phase 3 clinical trial evaluating the safety of co-administration of IDA and azithromycin for neglected tropical diseases (trachoma and ya…
-
CLINICAL_TRIALS trial_result · 2018-06-14Clinical Trial Update: Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis [Phase 3]
A Phase 3 randomized trial comparing multiple-dose versus single-dose ivermectin for the treatment of strongyloidiasis has completed.
-
CLINICAL_TRIALS trial_result · 2017-09-07Clinical Trial Update: Ivermectin Versus Albendazole for Chronic Strongyloidiasis [Phase 3]
Phase 3 trial comparing ivermectin to albendazole for chronic strongyloidiasis has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders
This completed clinical trial update reports on diagnosing a range of neglected tropical diseases in patients with persistent digestive diso…
-
FDA approval · 2009-10-20FDA Approved: ALBENDAZOLE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for Albendazole submitted by Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2009-08-25Clinical Trial Update: Study of Patients With Strongyloides Stercoralis Infection
This document notes the completion of a National Institute of Allergy and Infectious Diseases–sponsored trial evaluating patients with Stron…
-
FDA approval · 2008-02-26FDA Approved: STROMECTOL — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for Stromectol (ivermectin) filed by Merck Sharp & Dohme LLC, granting changes to the drug's labelin…